Skip to main content
Isomer
  1. Home
  2. Automated
  3. NDF A-Z listing
  4. Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine
M

Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine

Subsidy Information and Financing Scheme

No

Drug Guidance

No

Post-marketing information

No

Summary of Biologics

No

Active ingredients: Vaccine Meningococcal | Meningococcal Vaccine | Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine

General information

Subsidy Information and Financing Scheme

Not Applicable

Drug Guidance for Subsidy

Not Applicable

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Drug availability

Formulation

Public Healthcare Institution

Menactra® Injection, Solution, Diphtheria Toxoid Protein 48 mcg/dose (0.5 mL) (Diphtheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio) + Meningococcal (Serogroup A) Polysaccharide (Monovalent Conjugate) 4 mcg/dose (0.5 mL) + Meningococcal (Serogroup C) Polysaccharide (Monovalent Conjugate) 4 mcg/dose (0.5 mL) + Meningococcal (Serogroup W-135) Polysaccharide (Monovalent Conjugate) 4 mcg/dose (0.5 mL) + Meningococcal (Serogroup Y) Polysaccharide (Monovalent Conjugate) 4 mcg/dose (0.5 mL)

  1. Sengkang General Hospital

  2. Tan Tock Seng Hospital

Nimenrix Injection, Powder For Solution, Neisseria Meningitidis Group A Polysaccharide 5 micrograms + Neisseria Meningitidis Group C Polysaccharide 5 micrograms + Neisseria Meningitidis Group W-135 Polysaccharide 5 micrograms + Neisseria Meningitidis Group Y Polysaccharide 5 micrograms + Tetanus Toxoid Carrier Protein ~44 micrograms

  1. Changi General Hospital

  2. KK Women's and Children's Hospital

  3. Khoo Teck Puat Hospital

  4. National Cancer Centre

  5. Ng Teng Fong General Hospital

  6. Singapore General Hospital

  7. SingHealth Polyclinics

  8. Tan Tock Seng Hospital

  9. Woodlands Health Campus

Menveo Injection, Powder For Solution, (MenA Lyo) Meningococcal Group A oligosaccharide conjugated to CRM197 protein 10 microgram conjugated to 16.7-33.3 microgram + (MenCWY) Meningococcal Group C oligosaccharide conjugated to CRM197 protein 5 microgram conjugated to 7.1-12.5 microgram + (MenCWY) Meningococcal Group W-135 oligosaccharide conjugated to CRM197 protein 5 microgram conjugated to 3.3-8.3 microgram + (MenCWY) Meningococcal Group Y oligosaccharide conjugated to CRM197 protein 5 microgram conjugated to 5.6-10 microgram

  1. National University Hospital

  2. National University Polyclinics

  3. Tan Tock Seng Hospital

List of monographs containing this active ingredient

Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menactra®]

Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [MenQuadfi]

Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menveo]

Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Nimenrix]

Back to top